As of June 7, 2021:
The Healthwell Foundation has available funds for their co-pay assistance program. To learn if you qualify and how to apply, visit this Healthwell Foundation page.
The Patient Advocate Foundation (PAF) has available funds for their co-pay assistance program. To learn if you qualify and how to apply, visit this PAF page.
The Leukemia & Lymphoma Society (LLS) has available funds for their co-pay assistance program. To learn if you qualify and how to apply, visit this LLS page.
However, many other co-pay assistance programs are still unable to assist patients. If you have an existing grant, please check its status with that co-pay foundation. Links provided below:
If you are in need of co-pay assistance, we also encourage you to contact the patient support programs of the drug manufacturers directly:
Amgen
- Kyprolis
- Amgen Assist 360 Program
Bristol Myers Squibb
- ABECMA®
- Cell Therapy 360
- Thalomid (Thalidomide)®, Revlimid® (lenalidomide) and Pomalyst® (pomalidomide)
- BMS Access Support
GlaxoSmithKline
- BLENREP (belantamab mafodotin-blmf)
- GSKForYou | Patient Assistance Program
Janssen
- DARZALEX® (daratumumab)
DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) - Janssen CarePath Program
Karyopharm
- XPOVIO® (selinexor)
- KaryForward® Patient & Caregivers Support
Oncopeptides
- PEPAXTO® (melphalan flufenamide)
- ONCOURSE with Oncopeptides
Sanofi Genzyme
- SARCLISA® (isatuximab-irfc)
- CareASSIST Patient Support Program
Takeda